
Traditionally used as an anesthetic, new studies have found intranasal ketamine effective for treatment-resistant depression.
Rapid onset (at or around 24 hours) and sustained results give promise to this novel medication, with minimal adverse effects.
Resources:
Use left/right arrows to navigate the slideshow or swipe left/right if using a mobile device